Literature DB >> 20883782

Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer.

Nobuhiro Ijichi1, Takashi Shigekawa, Kazuhiro Ikeda, Kuniko Horie-Inoue, Tetsuya Fujimura, Hitoshi Tsuda, Akihiko Osaki, Toshiaki Saeki, Satoshi Inoue.   

Abstract

Breast cancer is primarily a hormone-dependent tumor that can be regulated by status of steroid hormones including estrogen and progesterone. Estrogen-related receptors (ERRs) are orphan nuclear receptors most closely related to estrogen receptor (ER) and much attention has been recently paid to the functions of ERRs in breast cancer in terms of the interactions with ER. In the present study, we investigated the expression of ERRγ in human invasive breast cancers by immunohistochemical analysis (n=110) obtained by radical mastectomy. Nuclear immunoreactivity of ERRγ was detected in 87 cases (79%) and tended to correlate with the lymph node status. No significant associations were observed with other clinicopathological characteristics, including the expression levels of both estrogen and progesterone receptors. In MCF-7 breast cancer cells, we demonstrated that ERRγ mRNA was up-regulated dose-dependently by estrogen, and that this up-regulation of ERRγ mRNA by estrogen was abolished by ICI 182,780 treatment. We also demonstrated that exogenously transfected ERRγ increased MCF-7 cell proliferation. Furthermore, ERRγ enhanced estrogen response element (ERE)-driven transcription in MCF-7 cells. In 293T cells, ERRγ could also stimulate ERE-mediated transcription with or without ERα. These results suggest that ERRγ plays an important role as a modulator of estrogen signaling in breast cancer cells.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20883782     DOI: 10.1016/j.jsbmb.2010.09.002

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  23 in total

1.  ERK/MAPK regulates ERRγ expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer.

Authors:  Mary M Heckler; Hemang Thakor; Cara C Schafer; Rebecca B Riggins
Journal:  FEBS J       Date:  2014-04-28       Impact factor: 5.542

Review 2.  Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond.

Authors:  Geneviève Deblois; Vincent Giguère
Journal:  Nat Rev Cancer       Date:  2012-11-29       Impact factor: 60.716

3.  Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.

Authors:  Nobuhiro Ijichi; Takashi Shigekawa; Kazuhiro Ikeda; Kuniko Horie-Inoue; Chikako Shimizu; Shigehira Saji; Kenjiro Aogi; Hitoshi Tsuda; Akihiko Osaki; Toshiaki Saeki; Satoshi Inoue
Journal:  Horm Cancer       Date:  2012-04-03       Impact factor: 3.869

4.  Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis.

Authors:  Hye-Young Nam; Darshan S Chandrashekar; Anirban Kundu; Sandeep Shelar; Eun-Young Kho; Guru Sonpavde; Gurudatta Naik; Pooja Ghatalia; Carolina B Livi; Sooryanarayana Varambally; Sunil Sudarshan
Journal:  Mol Cancer Res       Date:  2018-08-21       Impact factor: 5.852

5.  Insights into the activation mechanism of human estrogen-related receptor γ by environmental endocrine disruptors.

Authors:  Erwan Thouennon; Vanessa Delfosse; Rémy Bailly; Pauline Blanc; Abdelhay Boulahtouf; Marina Grimaldi; Alessandro Barducci; William Bourguet; Patrick Balaguer
Journal:  Cell Mol Life Sci       Date:  2019-05-24       Impact factor: 9.261

6.  Perinatal High-Fat Diet and Bisphenol A: Effects on Behavior and Gene Expression in the Medial Prefrontal Cortex.

Authors:  Leslie M Wise; Diego Hernández-Saavedra; Stephanie M Boas; Yuan-Xiang Pan; Janice M Juraska
Journal:  Dev Neurosci       Date:  2018-12-21       Impact factor: 2.984

7.  Neurodevelopmental low-dose bisphenol A exposure leads to early life-stage hyperactivity and learning deficits in adult zebrafish.

Authors:  Katerine S Saili; Margaret M Corvi; Daniel N Weber; Ami U Patel; Siba R Das; Jennifer Przybyla; Kim A Anderson; Robert L Tanguay
Journal:  Toxicology       Date:  2011-11-15       Impact factor: 4.221

8.  FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer.

Authors:  Takashi Shigekawa; Nobuhiro Ijichi; Kazuhiro Ikeda; Kuniko Horie-Inoue; Chikako Shimizu; Shigehira Saji; Kenjiro Aogi; Hitoshi Tsuda; Akihiko Osaki; Toshiaki Saeki; Satoshi Inoue
Journal:  Horm Cancer       Date:  2011-10       Impact factor: 3.869

9.  Estrogen-related Receptor β Reduces the Subnuclear Mobility of Estrogen Receptor α and Suppresses Estrogen-dependent Cellular Function.

Authors:  Takashi Tanida; Ken Ichi Matsuda; Shunji Yamada; Takashi Hashimoto; Mitsuhiro Kawata
Journal:  J Biol Chem       Date:  2015-03-24       Impact factor: 5.157

10.  Exposure to ionizing radiation induced persistent gene expression changes in mouse mammary gland.

Authors:  Kamal Datta; Daniel R Hyduke; Shubhankar Suman; Bo-Hyun Moon; Michael D Johnson; Albert J Fornace
Journal:  Radiat Oncol       Date:  2012-12-05       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.